Aurogra

Aurogra is a prescription medication specifically formulated to address erectile dysfunction (ED) in adult men. It contains Sildenafil Citrate, a potent phosphodiesterase type 5 (PDE5) inhibitor that enhances blood flow to the penile tissues, facilitating the achievement and maintenance of an erection sufficient for sexual activity. This medication is clinically proven, requires sexual stimulation for efficacy, and should be used under appropriate medical supervision to ensure safety and optimal therapeutic outcomes.

Features

• Active ingredient: Sildenafil Citrate 100mg
• Mechanism: Selective inhibition of phosphodiesterase type 5 (PDE5)
• Onset of action: Typically within 30–60 minutes post-administration
• Duration of effect: Up to 4–6 hours
• Formulation: Oral tablet
• Prescription requirement: Yes

Benefits

• Restores the ability to achieve and sustain erections adequate for sexual intercourse
• Improves confidence and reduces anxiety related to sexual performance
• Enhances overall sexual satisfaction for both partners
• Offers a predictable and reliable response when used as directed
• Supported by extensive clinical research and real-world usage data
• Non-hormonal mechanism with no effect on libido

Common use

Aurogra is primarily indicated for the treatment of erectile dysfunction, a condition characterized by the consistent inability to attain or maintain an erection sufficient for satisfactory sexual performance. It may also be used off-label under medical guidance for certain pulmonary hypertension conditions, though this application requires distinct dosing protocols and should only be pursued with explicit physician approval.

Dosage and direction

The standard recommended dose is one 100mg tablet taken orally approximately 30–60 minutes before anticipated sexual activity. Dosage may be adjusted based on individual efficacy and tolerability, with a maximum frequency of one dose per 24-hour period. Administration with a high-fat meal may delay onset of action. The tablet should be swallowed whole with a full glass of water; do not crush, split, or chew.

Precautions

• Cardiovascular status should be evaluated prior to initiation, as sexual activity carries potential cardiac risk
• Use with caution in patients with anatomical penile deformities, bleeding disorders, or active peptic ulceration
• Priapism (prolonged erection >4 hours) requires immediate medical attention to prevent permanent tissue damage
• Not intended for use by women, children, or adolescents
• Avoid concurrent consumption of grapefruit or grapefruit juice
• Caution advised in patients with severe hepatic or renal impairment

Contraindications

• Concomitant use of organic nitrates or nitric oxide donors in any form
• History of hypersensitivity to Sildenafil Citrate or any excipients in the formulation
• Patients with severe cardiovascular instability, hypotension, or recent myocardial infarction
• Hereditary degenerative retinal disorders
• Concomitant use with potent CYP3A4 inhibitors in patients with cardiovascular risk factors

Possible side effect

Common adverse reactions include headache, flushing, dyspepsia, nasal congestion, and dizziness. Less frequently reported effects comprise visual disturbances ( altered color perception, blurred vision), nausea, rash, and myalgia. Serious but rare side effects include sudden hearing loss, non-arteritic anterior ischemic optic neuropathy, and cardiovascular events. Most side effects are mild to moderate and transient in nature.

Drug interaction

• Absolute contraindication with nitrates due to risk of severe hypotension
• Potent CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) may increase Sildenafil exposure
• Alpha-blockers may potentiate hypotensive effects
• Interactions possible with other antihypertensives
• Caution with other PDE5 inhibitors or erectile dysfunction treatments

Missed dose

As Aurogra is taken on an as-needed basis rather than on a scheduled regimen, the concept of a “missed dose” does not apply. Do not take extra tablets to compensate for a missed opportunity; adhere strictly to the maximum dosing frequency of once per 24 hours.

Overdose

Symptoms may include severe headache, visual disturbances, nausea, dizziness, syncope, and prolonged erection. In cases of suspected overdose, seek immediate medical attention. Supportive measures should be implemented, with particular attention to cardiovascular status. Dialysis is not expected to enhance elimination due to high protein binding.

Storage

Store at room temperature (15–30°C) in the original container, protected from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.

Disclaimer

This information is provided for educational purposes only and does not constitute medical advice. Aurogra is a prescription medication that should only be used under the supervision of a qualified healthcare professional. Individual results may vary. Always consult with a physician for proper diagnosis and treatment recommendations based on your specific medical history and current health status.

Reviews

Clinical studies demonstrate that Aurogra (Sildenafil Citrate) achieves improved erections in 82% of men with erectile dysfunction, compared to 24% on placebo. Real-world evidence supports high patient satisfaction rates, with particular appreciation for its rapid onset and duration of action. Most reported side effects were mild and self-limiting. Healthcare providers consistently rate it as a first-line therapeutic option for erectile dysfunction when appropriately prescribed.